Skip to content
TEM·Nasdaq·US

Tempus AI

Tempus AI is a precision medicine company that combines clinical, genomic, imaging, and other multimodal data with AI to support diagnostics and treatment selection. It also commercializes data and analytics products for life sciences and healthcare customers.

Recent Activity

Updated Oct 24, 2026
–Pathos AI announced a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial intelligence tools for drug development.

Past updates are part of the Pro plan.

Thematic Position

TEM

Relationship Groups

Suppliers4
Customers1
Partners5
Licensing1
Competitors13

Relationship details are part of the Pro plan.

Ended Relationships

5 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

regulatory enforcementlicensing requirement
CLIA and state laboratory licensure requirements constrain Tempus AI lab operations
SEC 10-KFeb 24, 2026

The full regulatory passage is part of the Pro plan.

13 more · Regulatory and geopolitical insights are part of the Pro plan.